Drug research

Fulvestrant

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Faslodex

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsNCT01953926	PBYI	Phase 2	Terminated	2023-01-02Actual
A Pre-Surgical PK Study of IM and Intraductally Delivered FulvestrantNCT02540330	ATOS	Phase 2	Terminated	2020-08-13Actual
Phase 2a Study of ZW25 in Combination With Palbociclib Plus FulvestrantNCT04224272	Jazz Pharmaceuticals	Phase 2	Completed	2023-04-28Actual
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNCT06982521	RLAY	Phase 3	Recruiting	2028-04-30Estimated
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)NCT05501886	CELC	Phase 3	Active not recruiting	2026-06-30Estimated
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT06016738	OLMA	Phase 3	Active not recruiting	2026-10-31Estimated

PBYITerminatedPrimary completion: 2023-01-02 · Actual

Trial details

ATOSTerminatedPrimary completion: 2020-08-13 · Actual

Trial details

Jazz PharmaceuticalsCompletedPrimary completion: 2023-04-28 · Actual

Trial details

RLAYRecruitingPrimary completion: 2028-04-30 · Estimated

Trial details

CELCActive not recruitingPrimary completion: 2026-06-30 · Estimated

Trial details

OLMAActive not recruitingPrimary completion: 2026-10-31 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.